120 related articles for article (PubMed ID: 2005587)
1. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
Arts KS; Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1991 Mar; 256(3):890-6. PubMed ID: 2005587
[TBL] [Abstract][Full Text] [Related]
2. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms mediating tail-flick inhibition induced by beta-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1991 Apr; 257(1):530-8. PubMed ID: 2020008
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1086-92. PubMed ID: 1545380
[TBL] [Abstract][Full Text] [Related]
5. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
DeLander GE; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
[TBL] [Abstract][Full Text] [Related]
6. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
7. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
8. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
Fujimoto JM; Arts KS; Rady JJ; Tseng LF
Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
[TBL] [Abstract][Full Text] [Related]
9. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
Arts KS; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
[TBL] [Abstract][Full Text] [Related]
10. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
11. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
12. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
Fujimoto JM; Holmes B
J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
[TBL] [Abstract][Full Text] [Related]
13. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
14. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
Suh HH; Fujimoto JM; Tseng LL
Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
16. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
Jiang Q; Sheldon RJ; Porreca F
J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
Ossipov MH; Suarez LJ; Spaulding TC
Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
[TBL] [Abstract][Full Text] [Related]
18. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
19. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
Roerig SC; Hoffman RG; Takemori AE; Wilcox GL; Fujimoto JM
J Pharmacol Exp Ther; 1991 Jun; 257(3):1091-9. PubMed ID: 1646321
[TBL] [Abstract][Full Text] [Related]
20. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.
DeLander GE; Hopkins CJ
J Pharmacol Exp Ther; 1986 Oct; 239(1):88-93. PubMed ID: 2428975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]